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ABSTRACT
PURPOSE: The role of Ureaplasma urealyticum (U. urealyticum), Mycoplasma hominis (M. hominis) 
and Mycoplasma genitalium (M. genitalium) in male genital disorders deserves a more intensive research. 
The aim of this study was to determine the prevalence rate of these pathogens in symptomatic and asymp-
tomatic sexually active males in Bulgaria.
MATERIAL AND METHODS: A total of 260 symptomatic and asymptomatic men were included in the 
study. Their urethral swabs were examined for the presence of the mentioned microorganisms by using 
polymerase chain reaction (PCR).
RESULTS: The prevalence rates of these pathogens were the following: U. urealyticum - 4,6%; M. hominis - 
0,8%, and M. genitalium - 3,1%. No coinfections were registered at all.
CONCLUSION: The present investigation of these mycoplasmas is the first attempt to provide certain epide-
miological information about these infections in Bulgaria. Their continuous monitoring is of practical im-
portance for public health.
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 INTRODUCTION 
Genital mycoplasmas belong to the sexually 
transmitted infections that more and more frequent-
ly cause acute diseases, long-term disability and in-
fertility. However, these pathogens are not included 
in the routine microbiological diagnosis. Nowadays 
polymerase chain reaction (PCR) is the method of 
choice for their identification. 
The aim of this study was to establish the prev-
alence and clinical significance of U. urealyticum, M. 
hominis and M. genitalium in symptomatic and as-
ymptomatic sexually active men in Bulgaria by PCR 
examinations of their urethral swabs.
MATERIAL AND METHODS
The study covered a total of 260 males. A writ-
ten informed consent to participate in the study was 
obtained from each person. Dacron swabs were used 
to collect urethral specimens for the detection of the 
bacteria. They were put into a special transport me-
dium. The samples were transported within ~1 hour 
to the laboratory and examined either within the 
same day, or no longer than one week later on. 
Aliquots of the transport medium with the 
sample were used for PCR testing for the detection 
of fragments of U. urealyticum, M. hominis and M. 
genitalium. After vortexing the diluted sample was 
subjected to a DNA extraction using DNA extrac-
tion kit according to manufacturer’s requirements 
(Sacace Biotechnologies, Como, Italy). Detection of 
the pathogens was performed by applying PCR spe-
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cific primers according to Lee et al. (11). PCR was 
carried out with 4 µL of the template DNA, 0,25 µL 
of each primer (Alpha DNA, Canada), 0,2 mM (each) 
of the deoxyribonucleoside triphosphates, 1x Reac-
tion Buffer, MgCl
2
 (2 mM) and 1,5 U of Taq DNA 
polymerase (Prime TaqTM DNA Polymerase; GEN-
ET BIO) in a total volume of 25 µL. The DNA was 
amplified in a Techgen PCR thermocycler (Techne, 
England) using the following protocol: an initial de-
naturation 94 ºC, 5 min; 35 cycles (94 ºC, 40 sec; 54 
ºC, 45 sec; 72 ºC, 1 min 5 sec) and final extension 72 
ºC, 7 min. PCR products (12,5 µL of each amplifica-
tion) were separated in a 1,5% agarose gel for 45 min 
at 150 V, stained with ethidium bromide (0,5 µg/mL) 
and detected using UV transillumination (λ=312 
nm). Each PCR run was accompanied by a quality 
control. For positive control, U. urealyticum ATCC-
33699, M. hominis ATTC-14027 and M. genitalium 
ATCC-33530 were used. The negative controls in-
cluded distilled water and negative clinical samples 
selected at random.
Each DNA was subjected to a human β-globin 
PCR to ensure that amplifiable DNA was successful-
ly extracted from the sample and to monitor for PCR 
inhibitors (4). This β-globin PCR protocol was the 
same one listed for bacterial PCR, with the exception 
that the following primers were employed: GH2O, 
5’-GAAGAGCCAAGGACAGG TAC-3’, and PCO4, 
5’-CAACTTCATCCACGTTCACC-3’.
RESULTS
The swabs received from persons with or with-
out any genital complaints were used to evaluate the 
prevalence rate of U. urealyticum, M. hominis and M. 
genitalium infection.
U. urealyticum was found out in 12 swabs (in 
4,6%), M. hominis - in two samples (in 0,8%), and M. 
genitalium - in 8 symptomatic males (in 3,1%) (Table 
1). Coinfections were not detected at all. The high-
er relative share of positive findings was established 
in the symptomatic group of U. urealyticum and M. 
genitalium. 
DISCUSSION
In men, Ureaplasma spp. are the main cause of 
nonchlamydial, nongonococcal urethritis and acute 
prostatitis (3) M. genitalium  is associated with ure-
thritis (7,8,10), too, whereas  M. hominis  is related 
to pyelonephritis (3). Although genital mycoplas-
mas are established as relevant sexually transmitted 
pathogens little is known about these infections in 
Bulgarian males. 
It is considered that M. hominis does not pro-
voke urogenital disorders except in 5% of the cas-
es with pyelonephritis (17). There are contradictory 
opinions about the infertility caused by this micro-
organism. Some investigators register a prevalence 
rate of 1,3% of the infection among patients attend-
ing infertility clinics (9), while others detect a higher 
one - of 10,8% (6). In our study, M. hominis is proved 
in one male attending the Clinic for a prophylactic 
check-up. 
U. urealyticum is another genital microorgan-
ism which prevalence rate among healthy men var-
ies in a wide range - between 0% and 56% (12). The 
pathogen is detected in 5,6-42% among the patients 
with urethritis (5) and in 15-20,1% among those with 
infertility. In our study, its prevalence rate is 4,6%. 
In our study, M. genitalium prevalence rate is 
3,1%. Other authors establish a low prevalence rate of 
the infection in sexually active persons, too - 0,98% 
(13); 0,8% (2); 1,3% (15); 2,3% (1), and 3,7% (14). Sig-
nificantly higher literature data are reported con-
cerning the symptomatic patients with acute non-
gonococcal urethritis between 13,2% and 33,3% (16) 
and the persons with complains but without urethri-
tis - between 0% and 9,1% (18).
Clinical groups n U. urealyticum M. hominis M. genitalium
symptomatic* 200 8 0 6
infertility 48 4 0 2
prophylactic check-up 12 0 2 0
*predominant diagnosis of urethritis
Table 1. Detection of U. urealyticum, M. hominis and M. genitalium in males from different groups 
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There are scanty data about the prevalence 
rates, diagnostic methods and clinical significance of 
mycoplasmas in Bulgaria. In this respect, males are 
first examined in our country. The relatively lower 
prevalence rates of these three infections in Bulgar-
ia than those reported elsewhere could be due to the 
less expressed circulation of these pathogens as well 
as to the widespread usage of macrolides in our clin-
ical practice. 
CONCLUSION
U. urealyticum and M. genitalium are estab-
lished in symptomatic patients only while M. hom-
inis is detected in two patients attending the clinic 
for prophylactic checkup. The present investigation of 
these mycoplasmas is the first attempt to provide cer-
tain epidemiological information about these infec-
tions in Bulgaria. Their continuous monitoring is of 
practical importance for public health. 
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